Symbols

UNCY

Unicycive·NASDAQ

--(--)

UNCY Profile

Unicycive Therapeutics, Inc.

A biotech company that develops novel treatments for kidney diseases

Industry

Biological Technology

Established Date

08/18/2016

Listing Date

07/13/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.unicycive.com

Security Type

Common stock

Office address

1975 W. El Camino Real Suite 204 Mountain View CA 94040

Business

Introduction

Unicycive Therapeutics, Inc., was incorporated in Delaware on August 18, 2016. The company is a biotechnology company that develops treatments for certain medical conditions. Currently, the company's two projects focus on kidney disease. As the company grows and the team is established, the company intends to focus on identifying medical conditions inside and outside kidney disease. The company's current development programs focus on two new therapies: cyanide carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis, and UNI 494 for the treatment of acute kidney injury (AKI).